The Asia Pacific Dialyzer Market would witness market growth of 7.62% CAGR during the forecast period (2019-2025). Asia-Pacific is anticipated to experience the largest growth rate throughout the forecast period due to increased awareness among healthcare professionals about the use of home dialyzer for the treatment of kidney failure associated illnesses. Moreover, expanding healthcare expenditure, improving healthcare infrastructure, and growing medical tourism in the region would propel the market growth in Asia Pacific region.
The proven greater effectiveness of high-flux dialyzers to remove large-size toxin molecules during hemodialysis is expected to increase the development of high-flux dialyzers over the forecast period. Also, the greater compatibility of high-flux dialyzers for emerging technologies in hemodialysis such as hemodiafiltration and online hemodialysis is expected to increase the development of high-flux dialyzers on the dialyzer market by 2025.
Based on Type, the market is segmented into High-Flux Dialyzer and Low-Flux Dialyzer. Based on End User, the market is segmented into In-Center Dialysis and Home Dialysis. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., CVS Health Corporation, Fresenius Medical Care AG & Co. KGaA, DaVita, Inc., Asahi Kasei Corporation, Cardinal Health, Inc., Cantel Medical Corporation, Nipro Corporation, Allmed Medical Care Holdings Limited and Terumo Corporation.
Market Segmentation:
By Type
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
